Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
OTC Markets | Financial | Investment Holding Companies | US$3M | -40x | -0.68 | US$0.0002 | 0% | US$0.0001 | -25.2% Downside | Overvalued | Good | ||||
NASDAQ | Technology | Software & IT Services | US$1.41B | -7.4x | -0.25 | US$4.47 | 8.2% | US$4.95 | 23.9% Upside | Undervalued | US$5.50 | 35.1% Upside | Fair | ||
NASDAQ | Technology | Software & IT Services | US$14.90M | -1.6x | -0.03 | US$4.60 | 8% | US$5.15 | 12.1% Upside | Fair | US$13 | 216.3% Upside | Fair | ||
NASDAQ | Healthcare | Healthcare Equipment & Supplies | US$106.31M | -7.5x | -0.15 | US$3.07 | -26.4% | US$1.76 | -57.2% Downside | Expensive | Fair | ||||
NYSE | Consumer Cyclicals | Specialty Retailers | US$26.32B | 22.6x | 0.2 | US$128.72 | -3.1% | US$128.47 | 1.5% Upside | Fair | US$110 | -7.9% Downside | Good | ||
NASDAQ | Industrials | Professional & Commercial Services | US$55.42M | -3.5x | -0.08 | US$2 | -13% | US$2.25 | 18.7% Upside | Undervalued | Fair | ||||
NYSE | Technology | Software & IT Services | US$1.22B | -10.1x | -0.32 | US$21.20 | 0.2% | US$24.84 | 14% Upside | Fair | US$29 | 43.1% Upside | Good | ||
OTC Markets | Consumer Non-Cyclicals | Food & Tobacco | US$18.70M | -21.4x | -0.49 | US$0.007 | 15.8% | US$0.006 | -26.8% Downside | Overvalued | Fair | ||||
NASDAQ | Healthcare | Biotechnology & Medical Research | US$2.55B | 61x | 0.52 | US$17.79 | -0.9% | US$19.20 | 8.3% Upside | Fair | US$34.50 | 87.4% Upside | Great | ||
OTC Markets | Financial | Investment Holding Companies | US$11.64M | -21.6x | -0.26 | US$0.03 | 11.1% | US$0.01 | -46% Downside | Overvalued | Great | ||||
NASDAQ | Healthcare | Pharmaceuticals | US$235.25M | -2x | 0 | US$4.06 | 2.8% | US$3.94 | 3.2% Upside | Fair | US$13 | 218.2% Upside | Fair | ||
NASDAQ | Industrials | Machinery, Tools, Heavy Vehicles, Trains & Ships | US$2.63B | -13.1x | 2.03 | US$15.46 | -1.5% | US$13.30 | -11.5% Downside | Fair | US$22 | 86.9% Upside | Weak | ||
NASDAQ | Healthcare | Healthcare Equipment & Supplies | US$331.87M | -5.9x | -0.17 | US$6.67 | 2% | US$5.67 | -10.2% Downside | Fair | US$6 | -2.8% Downside | Good | ||
OTC Markets | Industrials | Professional & Commercial Services | US$11.86M | -4.2x | 0.02 | US$0.13 | 5.7% | US$0.08 | -37.1% Downside | Overvalued | Fair | ||||
NASDAQ | Healthcare | Biotechnology & Medical Research | US$810.53M | -4.5x | 0.03 | US$15.53 | 7.9% | US$16.20 | 15.6% Upside | Fair | US$17.50 | 21.6% Upside | Good | ||
OTC Markets | Energy | Oil & Gas | US$5.24M | 20x | 0.14 | US$0.09 | 6.3% | US$0.07 | -14.8% Downside | Fair | Good | ||||
OTC Markets | Financial | Investment Banking & Investment Services | US$7.07M | -7.3x | 0.07 | US$0.005 | 23.9% | US$0.002 | -48.7% Downside | Overvalued | Fair | ||||
NASDAQ | Healthcare | Healthcare Equipment & Supplies | US$987.25M | -15.1x | -0.27 | US$21.43 | 4.5% | US$24.62 | 14.6% Upside | Fair | US$25 | 16.2% Upside | Good | ||
NASDAQ | Healthcare | Biotechnology & Medical Research | US$1.73B | -7.2x | -0.63 | US$19.21 | -1.7% | US$21.99 | 12.8% Upside | Fair | US$36.89 | 85.4% Upside | Fair | ||
OTC Markets | Healthcare | Biotechnology & Medical Research | US$5.83M | -4.4x | 0.07 | US$0.04 | -11.4% | US$0.02 | -43.6% Downside | Overvalued | Good | ||||
NASDAQ | Consumer Cyclicals | Textiles & Apparel | US$274.36M | 20x | 5.97 | US$36.96 | 2.2% | US$34.73 | -1.3% Downside | Fair | US$32 | -13.1% Downside | Good | ||
NASDAQ | Healthcare | Biotechnology & Medical Research | US$1.08B | -3.4x | -0.09 | US$9.30 | -1.3% | US$11.12 | 19.8% Upside | Undervalued | US$18.50 | 108.3% Upside | Fair | ||
NYSE | Healthcare | Pharmaceuticals | US$357.38M | -0.6x | 0.02 | US$6.82 | -2.3% | US$8.79 | 33.9% Upside | Undervalued | US$8 | 18.2% Upside | Good | ||
NASDAQ | Healthcare | Pharmaceuticals | US$1.06B | -5.6x | 1.01 | US$6.84 | 1.2% | US$5.77 | -12.9% Downside | Fair | US$14.50 | 122.1% Upside | Good | ||
NASDAQ | Healthcare | Biotechnology & Medical Research | US$5.85B | -57.7x | -86.24 | US$53.01 | 4.4% | US$35.22 | -25.7% Downside | Overvalued | US$113 | 122.6% Upside | Good | ||
NASDAQ | Consumer Cyclicals | Hotels & Entertainment Services | US$516.59M | -9.3x | -0.3 | US$9.65 | 1.9% | US$7.71 | -14.9% Downside | Fair | US$12.50 | 54.9% Upside | Good | ||
NASDAQ | Technology | Semiconductors & Semiconductor Equipment | US$2.84B | -30.1x | 0 | US$124.38 | 0.9% | US$112.66 | -7.4% Downside | Fair | US$140 | 20.9% Upside | Fair | ||
OTC Markets | Technology | Software & IT Services | US$100.16M | -9.1x | -0.18 | US$0.0002 | 100% | US$0.00008 | -22.5% Downside | Overvalued | Weak | ||||
NYSE | Consumer Cyclicals | Hotels & Entertainment Services | US$10.58B | 261.8x | 3.49 | US$92.75 | 1.3% | US$56.19 | -37.6% Downside | Overvalued | US$90 | -1% Downside | Good | ||
OTC Markets | Industrials | Professional & Commercial Services | US$990.02K | 1.9x | 0.01 | US$0.12 | 18.8% | US$0.16 | 62% Upside | Bargain | Great |